Russian Satellite-V COVID-19 vaccine 91.4% effective

Russian Satellite-V COVID-19 vaccine 91.4% effective, “100% effective” for severe cases. According to today’s Russian television (RT) report, Russia is about to launch a nationwide large-scale vaccination program. On Monday, vaccine developers said that after large-scale trials, Russia’s first “satellite V” vaccine has been proven to be effective against the new coronavirus. 91.4%.

In a statement, Moscow’s “Gamalea” National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), which funded vaccine development, cited data from volunteers tested 21 days after the first dose of vaccine. It was announced that the results confirmed an overall effectiveness of 91.4% and showed that the vaccine is “100%” effective in severe cases. This means that although some vaccinators may still be infected with the new coronavirus, their condition will be milder.

The statement said: “Among the confirmed cases of new coronavirus infection, 20 severe cases were recorded in the placebo group, while no severe cases were recorded in the vaccine group.”

According to the National Research Center for Epidemiology and Microbiology of “Gamalea”, the third phase of clinical trials of the “Satellite V” vaccine was conducted in strict accordance with international practices and standards.

The institute stated that the vaccine has confirmed a high efficiency in each of the three clinical trials and will continue to apply for “accelerated registration” in various countries.

Denis Logunov, deputy director of the “Gamalea” Center, said: “The important thing is that the vaccine effective rate calculated at each stage must exceed 90%.” He also said that the institute will share the research results with international scientific groups, and Participants will continue to be monitored.

According to reports, more than 50 countries have applied for the purchase of more than 1.2 billion doses of vaccines, and the vaccines for international distribution will be produced in India, Brazil, China, South Korea and other countries.

Russia started a mass vaccination program earlier this month, and Kremlin spokesman Dmitry Peskov (Dmitry Peskov) said last week that vaccination will be extended to all regions of Russia by the end of this year.

On August 11, the “Satellite V” vaccine was registered with the Russian Ministry of Health, becoming the world’s first registered vaccine against new coronavirus pneumonia.

Disclaimer of medicaltrend.org